AMA responds to administration blueprint to tackle rising drug prices

| 1 Min Read

CHICAGO — The American Medical Association (AMA) sent the following letter in response to the Trump Administration’s request for comments to its plan to lower drug prices. The letter from AMA CEO and Executive Vice President James L. Madara, M.D., was sent to Health and Human Services Secretary Alex M. Azar II.

 

 

 

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Doctor with text bubbles and graphic elements

Deepfake “doctors” are a problem—here are 7 keys to stopping them

| 4 Min Read
Light bulb with

How to bring physician well-being initiatives to life

| 14 Min Read
Healthcare worker in empty hospital operating room

These physician specialties score highest on resident well-being

| 11 Min Read
Train passenger distressed by motion sickness

What doctors want patients to know about motion sickness

| 10 Min Read